Biomarker for measurement of response and prognosis of triple-negative breast cancer to anticancer agent
US-11339446-B2 · May 24, 2022 · US
Park Ae-Kyung is listed as an inventor on 2 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Park Ae-Kyung |
| Total patents | 2 |
| First publication | Mar 19, 2020 |
| Latest publication | May 24, 2022 |
Publications ranked by popularity score, then publication date.
Latest publications not already listed above.
No data yet.
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Seoul Nat Univ R&Db Foundation | 2 |
| Industry Academic Cooperation Foundation Of Sunchon National Univ | 2 |
| Seoul Nat Univ Hospital | 2 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C12Q2600/106 | 2 |
| C12Q2600/158 | 2 |
| C12Q1/6886 | 2 |
| G01N33/575 | 2 |
| C12Q2600/118 | 2 |